Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. (Q45385115)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2009

Language	Label	Description	Also known as
English	Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.	scientific article published in January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

(E)-phytonadione

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Young Joon Yoon

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Do Young Kim

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

861-866

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Epidemiology and natural history of hepatitis B.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Surveillance for hepatocellular carcinoma and early diagnosis

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Serological markers of liver cancer.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Alphafetoprotein: an obituary.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F00365520902903034

21 January 2018

Identifiers

10.1080/00365520902903034

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

release_rycd5pikebd47m6lqtln626j4i

1 reference

https://api.fatcat.wiki/v0/release/rycd5pikebd47m6lqtln626j4i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19391065%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45385115&oldid=1840285585"